Stay updated on Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.
Latest updates to the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this aspect.SummaryDifference0.2%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key links related to genetics, breast cancer, and drug information have been removed, which may impact access to important medical resources.SummaryDifference3%
- Check60 days agoChange DetectedThe website has been updated to version v2.12.2, with new additions including links to MedlinePlus and DailyMed for breast cancer and various treatments, while the previous version v2.12.1 has been removed.SummaryDifference3%
- Check74 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.